The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence Research

8 Mar 2018 11:00

RNS Number : 1281H
Standard Life Private Eqty Trst PLC
08 March 2018
 

Standard Life Private Equity Trust plc: New research

08/03/2018

Standard Life Private Equity Trust is a 'pure' private equity play (with no co-investments) and the only one of its kind without a performance fee...

Click here to read the full report

 

Highlights:

· A "pure" fund of funds (with no co-investments) representing SL Capital's highest conviction private equity manager selections in Europe and increasingly in North America, and is the only such trust with no performance fee

· Standard Life Private Equity Trust plc (SLPE) has a more concentrated portfolio relative to Pantheon or HarbourVest's very diversified funds, although in our view, slightly less concentrated when compared to a fund of funds (FoF) such as ICG Enterprise and F&C Private Equity

· The company expects the exposure to North America to gradually increase, and will continue to target secondary investments to take advantage of attractive investment opportunities and help reduce cash drag. SLPE currently has c.15% of NAV in cash, and on a commitment-cover basis registers at 0.6x, (according to JPMorgan Cazenove) which is very much in-line with the FoF peers

· strong performance over recent years and the "enhanced" dividend, (paid from a combination of income and capital) which currently yields 3.6%, has helped narrow the discount to 11%, slightly narrower than the peer group

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Important information - non-independent research

Standard Life Investments a client of Kepler Trust Intelligence. This research should be considered a marketing communication, and is not independent research.

This report has been approved under section 21 of the Financial Services and Markets Act 2000 by Kepler Partners LLP for communication to retail clients and private persons as defined by the Financial Services Authority. This is a marketing document, and should be considered non-independent research as defined in COBS 12.3.2R. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules. This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell. Any prices or quotations contained herein are indicative only. The information in this report is believed to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Please remember that past performance is not necessarily a guide to the future. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. Independent financial advice should be taken before entering into any financial transaction. Kepler Partners LLP is a limited liability partnership registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771. Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority.

 

Click here to read our terms and conditions.

 

About this service

Kepler Trust Intelligence for private investors is not just another news and research website. Our aim is to create a library of high quality investment strategy research, fund analysis and useful guides for private investors, all written in-house by experienced analysts on the investment companies team at Kepler Partners.

 

We are focused entirely on investment trusts, however we believe that it helps to understand them better if they are placed on a level playing field with OEICs, so you will see comparisons between the two in these pages often.

 

Our content falls into three categories;

 

· Investment strategy articles are designed to highlight opportunities and developments which are of interest to investment trust investors, positive or negative.

 

· Fund research focuses on individual trusts, examining them in detail to create a snapshot picture which you can use to decide whether or not you want to invest in them.

 

· Educational output is split into simple guides, designed to help beginners understand how investment trusts work, and more complex guides to sectors, regions and strategies which may be of interest to investors.

 

We do not produce massive amounts of research. Our focus is on quality, not quantity, so we are unlikely to publish more than four or five articles in a given week. For this reason we recommend that you join our mailing list, and we'll send you an email once a week alerting you to what's new on the site. We won't sell your details, and we won't spam you with useless updates.

 

How are we funded?

 

 

Our revenues are based on advertising from the asset management groups, which run investment trusts, and want exposure to an audience which is engaged with authentic, useful content.

Our advertisers can insert links to their own material - videos for example - into the content, and they can pay for a page where they can talk about their own products in the edition.

Investment trusts can also pay for us to write a piece of research about them specifically, and where we do this will be clearly marked as 'non-independent research'.

Where we do produce research on a 'paid-for' basis we strive to ensure that a clear, useful picture of the trust in question is the result, not just a puff piece.

We provide information, not advice

While we hope that you find the research we publish useful, and we believe it will help you to make a more informed decision, but we must of course stress that none of the research published here constitutes a recommendation, or advice, and you should not think that - just because we've published a report on a trust - we believe that trust is a 'buy'. Please read our terms and conditions.

If you want to manage your own investments we hope that this website is a useful source of information which helps you to do that, however if you are in any doubt, you should speak to a financial adviser.

 

Pascal Dowling

 

Kepler Partners

 

pascal@keplerpartners.com

 

www.trustintelligence.co.uk

 

www.keplerpartners.com

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKFDPKBKDCNK
Date   Source Headline
4th Dec 20177:00 amRNSAnnual Financial Report
30th Nov 20174:49 pmRNSDirectorate Change
14th Nov 20177:00 amRNSEstimated Net Asset Value at 31 October 2017
9th Nov 20174:50 pmRNSHolding(s) in Company
16th Oct 20174:14 pmRNSHolding(s) in Company
13th Oct 20177:00 amRNSEstimated Net Asset Value at 30 September 2017
3rd Oct 201712:37 pmRNSQuarterly Disclosure
20th Sep 20177:00 amRNSEstimated Net Asset Value at 31 August 2017
20th Sep 20177:00 amRNSQuarterly Trading Statement
13th Sep 20175:05 pmRNSDirector Declaration
25th Aug 20174:38 pmRNSDirector/PDMR Shareholding
17th Aug 20174:08 pmRNSHolding(s) in Company
14th Aug 20177:00 amRNSEstimated Net Asset Value at 31 July 2017
10th Aug 20174:08 pmRNSDirector/PDMR Shareholding
4th Aug 20171:54 pmRNSDirector/PDMR Shareholding
4th Aug 20171:53 pmRNSDirector/PDMR Shareholding
14th Jul 20177:00 amRNSEstimated Net Asset Value at 30 June 2017
4th Jul 201712:59 pmRNSQuarterly Disclosure
3rd Jul 20172:46 pmRNSUpdate research from QuotedData
14th Jun 20177:00 amRNSEstimated Net Asset Value at 31 May 2017
7th Jun 20171:48 pmRNSDirector/PDMR Shareholding
7th Jun 20177:00 amRNSHalf-year Report
15th May 20177:00 amRNSEstimated Net Asset Value at 30 April 2017
8th May 20174:48 pmRNSHolding(s) in Company
2nd May 20171:09 pmRNSEdison update on Standard Life Private Eqty Trst
18th Apr 20177:00 amRNSEstimated Net Asset Value at 31 March 2017
4th Apr 201712:34 pmRNSQuarterly Disclosure
24th Mar 20177:00 amRNSEstimated Net Asset Value at 28 February 2017
24th Mar 20177:00 amRNSQuarterly Trading Statement
22nd Feb 201710:22 amRNSUpdate research from QuotedData
14th Feb 20177:00 amRNSEstimated Net Asset Value at 31 January 2017
7th Feb 20179:38 amRNSDirector/PDMR Shareholding
7th Feb 20179:37 amRNSDirector/PDMR Shareholding
31st Jan 20173:09 pmRNSChange of Name
24th Jan 20172:18 pmRNSResult of AGM
16th Jan 20177:00 amRNSEstimated Net Asset Value at 31 December 2016
4th Jan 20172:24 pmRNSQuarterly Disclosure
21st Dec 201612:33 pmRNSHolding(s) in Company
21st Dec 20167:00 amRNSChange of Broker
14th Dec 20167:00 amRNSEstimated Net Asset Value at 30 November 2016
5th Dec 201611:21 amRNSAnnual Report and Notice of Annual General Meeting
5th Dec 20167:00 amRNSChange of Advisors
5th Dec 20167:00 amRNSEstimated Net Asset Value at 31 October 2016
5th Dec 20167:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Dec 20167:00 amRNSAnnual Financial Report
14th Nov 20167:00 amRNSEstimated Net Asset Values as at 31 October 2016
7th Nov 201611:04 amRNSEdison review: Standard Life Euro Priv Eqty Trst
14th Oct 20167:00 amRNSEstimated Net Asset Value as at 30 September 2016
10th Oct 20163:53 pmRNSDirector Declaration
6th Oct 201611:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.